TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.8 CNY | +2.98% |
|
+2.98% | -10.38% |
| 03-01 | Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue | MT |
| 02-29 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Tianjin Chase Sun Pharmaceutical Co.,Ltd
Price target over the last 5 years
History of analyst recommendation changes
77914224d3cd.K_5vfkrvUMyVKYid6AlEh9URLrfdz1EoLErhmCjM9W4.RLo4NjOoffnzYOTW2Egc1axHeY-YomcFAS-18Ru0mz59yi4sG6xltsEb0Q~1f9292fb5c5f895af566eb013940e043
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.8
CNY
Average target price
4
CNY
Spread / Average Target
+5.26%
High Price Target
4
CNY
Spread / Highest target
+5.26%
Low Price Target
4
CNY
Spread / Lowest Target
+5.26%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 300026 Stock
- Consensus Tianjin Chase Sun Pharmaceutical Co.,Ltd
